






                                                      Abstract 
 
Objective: To investigate the effect of maternal pre-pregnancy body mass index on 
maternal morbidity in the United States. 
Methods: Maternal pre-pregnancy body mass index was categorized as follow: 
underweight (<18.5), normal (18.5-24.9), overweight (25.0-29.9), and obesity (≥30). The 
odds ratio (OR) and 95% CIs of maternal morbidity by pre-pregnancy BMI were 
estimated by multivariable adjusted logistic regression models. 
Results: There were 355 cases of maternal morbidity. Compared with obese women, 
the adjusted ORs (95%CIs) for maternal morbidity in underweight, normal, and 
overweight women were 0.47 (0.21- 1.08), 1.00 (0.78-1.30), 0.81(0.60-1.08) 
respectively. 
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    The target of Millennium Developmental Goal 5 was to achieve 75% reduction in 
maternal mortality between 1990 and 2015. * Maternal mortality ratio is one of the 
main indicators of maternal health status in any given country. The target of the 
Sustainable Developmental Goals is to reduce the global maternal mortality ratio 
to less than 70 per 100 000 live births between 2016- and 2030. ** While the ratio of 
maternal mortality to acute maternal morbidity is 1:20 it is 1:30 for chronic maternal 
morbidity1. Maternal morbidity is a complex area with a wide spectrum of severity 
and presentation.1 Recently the World Health Organization(WHO) defined 
Maternal morbidity as ‘‘any health condition attributed to and/or aggravated by 
pregnancy and childbirth that has a negative impact on the woman’s wellbeing’’.1 
Finding an accurate identification of maternal morbidity in a reliable consistent way 
is challenging, and still, very little information is known about maternal morbidity.  
       Maternal mortality and morbidity in the United States of America: 
 
       Maternal mortality and morbidity remains a challenge in the United States.2 
Between 1990 and 2013, the maternal mortality ratio for the USA increased from 12 
to 28 maternal deaths per 100 000 births.2 About half of all maternal deaths in the 
USA are preventable.3 Three factors may be contributing to the increase in maternal 
mortality and morbidity in the USA. First, inconsistent obstetric practices (variations in 
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treatment); hospitals lack the standard management of obstetric emergencies and the 
early detection of pregnancy and childbirth complications. Nationally supported 
strategies to manage obstetric emergencies and updated training and guidance on 
implementing these strategies is an important need.4 Second, the increasing number 
of women who seek antenatal care with preexisting chronic conditions, such as 
hypertension, diabetes and obesity, which increase pregnancy-related complications. 
Many of these women could benefit from the closer coordination of antenatal and 
primary care.5 Third, lack of high quality data and related analysis on maternal health 
outcomes. Only 50% of the states have maternal mortality review boards and the data 
that are collected are not systematically used to guide changes that could decrease 
maternal mortality and morbidity.5 
       Recent research has shown that increased prevalence of obesity and hypertension 
both before and during pregnancy is associated with severe maternal morbidity.6 This 
study will focus on the incidence of any of the four maternal morbidities reported on 
the birth certificate: maternal transfusion, ruptured uterus, unplanned hysterectomy, 
and ICU admission. The rates are compared among the different classes of maternal 
BMI to study the effect of overweight and obesity on maternal morbidity. Obese 
women may enter pregnancy with existing conditions such as hypertension, thus 
increasing the likelihood of pregnancy related morbidity and mortality. Pregnancy 
associated hypertension is another clinical factor that contributed to the trend of rising 
maternal morbidity.6 Another contributing factor for the increased maternal morbidity 
is the increase in the number of births to older women, who tend to have more health 
problems than younger women.7 Reducing racial and ethnic disparities in maternal 
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health should be a priority to decrease maternal morbidity as maternal morbidity is 
more pronounced in racial and ethnic minorities in the United States.8    This study will 
focus on one of the three major factors thought to be driving the increase in maternal 
morbidity and mortality in the US—maternal obesity. Obesity during pregnancy is an 
important cause for maternal morbidity. It is associated with an increase in maternal 
morbidity and a tenfold increase in the prevalence of hypertension. The rising 
epidemic of obesity has gained global attention as a major public health problem.9 In 
general, Obesity is a main risk factor for chronic diseases such as hypertension and 
cardiovascular disease.9 
 









This study is a retrospective secondary data analysis of the data collected from the 
January 1st -December 31st 2015 United States Natality Public Use File 
Documentation. Our main aim was to investigate the effect of maternal prepregnancy 
body mass index (BMI) on the maternal morbidity and the effects of maternal pre-
pregnancy body mass index (BMI) and having a diagnosis of pregnancy- associated 
hypertension on maternal morbidity. Specifically, we seek to compare maternal 
morbidity (MM) among women with different body mass index (BMI) classes. We 
hypothesized that maternal body mass index (BMI) classes are predictive of maternal 
morbidity. Also, maternal body mass index (BM) classes and a diagnosis of 
pregnancy associated hypertension are predictive of maternal morbidity. 
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 Conceptual Model: Our Independent variable (Exposure) is maternal pre-pregnancy 
body mass index (BMI), defined as weight in kilograms divided by height in meters 
squared. Body mass index (BMI) < 18.5 kg/m2 (group 1; underweight), 18.5 to 24.9 
(group 2; normal), 25.0 to 29.9 (group 3; overweight), 30.0 to ≥ 40.0 (group 4; obese). 
The dependent variable (Outcome) is a composite of maternal morbidity consisting of 
maternal transfusion, ruptured uterus, unplanned hysterectomy, and admission to 
intensive care unit. Our mediator is having a diagnosis of Pregnancy-Associated 
Hypertension. We hypothesized that Pregnancy-Associated Hypertension is 
influenced by our independent variable and, in turn, affects our dependent variable. 
This is also called an indirect effect of the independent variable on the dependent 
variable. Our moderator is the number of prenatal visits, a variable that changes the 
effect of the independent variable on the dependent variable. Our confounders are 
maternal age and race. We hypothesized that increased body mass index (BMI) 
classes are associated with increased maternal morbidity. This relation is affected by 






BMI and Maternal Morbidity: In 2011-2014, more than 36% of adults in the United 
States were obese10, which is higher than the Healthy People 2020 goal of 30.5%.11 The 
prevalence of obesity was higher among women (38.3%) compared with men (34.3%), 
and among non-Hispanic white, non-Hispanic black and Hispanic adults compared with 
non- Hispanic Asian.10One retrospective cohort study revealed that as the BMI 
increases, women tend to have more prenatal visits, be older, have higher incidence of 
pregnancy related hypertension, and interestingly associated with longer surgical times 
and wound infections after hysterectomy.12Although the focus of this study was to 
examine the effect of BMI on the peripartum hysterectomies as they excluded 
scheduled hysterectomies, it came short in terms of how generalizable the results are to 















Another study with the focus to understand the causes of pregnancy related death in 
Virginia found higher maternal mortality ratio among women within the obese BMI 
class.13 Although this study confirms the association of obese BMI class with maternal 
mortality, the results were significant for the state of Virginia only with no evidence if we 
can generalize the results nationwide. The focus of the study was mainly the maternal 
mortality not morbidity. 
Pregnancy related Hypertension and Maternal Morbidity: 
 Approximately 17% of maternal mortality in the United States is due to hypertensive 
disorders of pregnancy.14 Pregnancy associated hypertension is defined as: the 
incidence of new-onset hypertension after 20 weeks of gestation, in the absence of 
accompanying proteinuria.15  
Hypertensive disorder of pregnancy is the most common causes of admission of 
pregnant/postpartum women to intensive care.16 One retrospective study based on all 
obstetric admission to ICN at specific hospital in France found that hypertensive 
disorders of pregnancy particularly preeclampsia is responsible for 26.7% of the 
indications for intensive care admissions.17Another study which is retrospective case-
control study based on obstetric admissions to the ICU at a hospital in London, UK 
revealed that, Hypertensive disorders was the main indications for Intensive care 
admission (39.4%) followed by  obstetric hemorrhage (36.4%).18A systematic review 
indications of intensive care admission for women who are either pregnant or up to 6 
weeks postpartum found that hypertensive disorders of pregnancy were the most 
prevalent indication for ICU admission.19 
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Age and Maternal Morbidity:  
One retrospective cohort study found that one of the risk factors for maternal morbidity 
is advanced maternal age.20 A case- control study based on a rural maternity clinic in 
Haiti found that older maternal age at delivery (OR = 3.18; 95%CI: 1.31, 7.76) and 
higher maternal weight (OR = 3.24; 95%CI: 1.76, 5.98) were significantly associated 
with pregnancy related hypertensive disorders. Interestingly, Prenatal care was not 
significantly associated with a reduction in the risk for hypertensive disorder of 
pregnancy.21 
Another study based on clinical data collected from 39 hospitals in China, revealed that 
the risk of pregnancy-induced hypertension increases gradually with maternal age 
greater than 35 years old and the risks of preeclampsia and eclampsia increase in 
teenage pregnancy.22 
Race and maternal morbidity: 
Racial and ethnic disparities persist in maternal morbidity, with non-Hispanic black 
women having the highest rates among other race groups.8 The pregnancy-related 
mortality ratios 2011-2013 were12.1 death per 100,000 live births for white women, 40.4 
deaths per 100,000 live births for black women, and16.4 deaths per 100,000 live births 
for women of other races.8 
One study used data collected from the National Health and Nutrition Examination 
Survey found that, non-Hispanic blacks have the highest age-adjusted rates of obesity 




A retrospective cohort study in California found that the risk factors for Hypertensive 
disorder of pregnancy are being Black (OR 1.46 [1.19-1.80]) and Hispanic race (OR 
1.56 [1.35-1.79]), maternal age ≤ 20 (OR 1.85 [1.61-2.11]), and <5 prenatal care visits 
(1.74 [1.46-2.07]).23 
Number of prenatal visits and Maternal morbidity: 
Recently the World Health Organization increased the recommended number of 
prenatal visits from four to eight.24 Evidences have shown that increasing the number of 
antenatal contacts by women and adolescent girls with their healthcare provider is 
associated with a reduction in both maternal and child adverse outcomes. Increase the 




The Data are from the 2015 United States Natality Public Use File Documentation 
obtained from the birth certificates. We are using a random sample that represent 2% of 
all births registered in the 50 states, the District of Columbia, and New York City. The 
sample is generalizable to the entire United States in 2015. The participants of this 
population- based observational study were 79,775 women. After complete case 
analysis, it decreased to 74,059 births (Table 1A).  






The vital statistics system captures data from all filled birth certificates, it is less likely to 
experience sampling and nonresponse biases than smaller samples, either probabilistic 
or non-probabilistic. Still, it is possible, that a small subset of births might not be 
captured in the data set, such as women who gave birth at home. Our exposure is the 
maternal pre-pregnancy body mass index, it was categorized as follow:  underweight 
(<18.5), normal (18.5-24.9), overweight (25.0-29.9), and obese (≥30) (table 1B).  
Table1B: Participant characteristic by Pre-Pregnancy Body Mass Index, 74,059 Births, The United States 





Our outcome is maternal morbidity; a composite of maternal transfusion, ruptured 
uterus, unplanned hysterectomy, and admission to intensive care unit. Maternal 
morbidity is coded as a binary variable where “Yes” refers to the presence of maternal 
morbidity and “No” refers to the absence of maternal morbidity (Table2).  
Table 2: Maternal Morbidity by Pre-Pregnancy Body Mass Index, 74,059 Births, The United States birth 
certificates, 2015 
 
Participants demographics and comorbidities include age, race, and pregnancy 
associated hypertension; we coded age as follow: less than 20 years (group1), 20-34 
years (group 2), and ≥35 (group3). Race was coded as: Non-Hispanic White (group 1), 
Non-Hispanic Black (group2), Hispanic (group3), and other (group4). Maternal Age and 
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race were included as potential confounders, age and race are associated with both 
BMI and maternal morbidity and are not in the causal pathway between BMI and 
maternal morbidity.  Pregnancy associated hypertension was coded as Yes and No 
where “Yes” refers to having a diagnosis of pregnancy associated hypertension. 
Pregnancy associated hypertension is a potential mediator in the causal pathway 
between BMI and maternal morbidity. The number of prenatal care visits was the 
moderator. We coded the number of prenatal visits as follow: 0-7 visits (group1), 8-15 
visits (group2), and 16- 70 visits (group3). All statistical tests were formed using STATA 
(StataCorp. 2017. Stata Statistical Software: Release 15. College Station, TX: 
StataCorp LLC). We first created three distinct logistic regression models. The first, 
unadjusted model, explored the individual effect of each of the components of our 
conceptual model [Figure 2] on the maternal morbidity. The second model was adjusted 
to control for maternal age, race, BMI. The third adjusted model built on model two to 
include the role of pregnancy associated hypertension and number of prenatal care 
visits. To explore the moderator [number of prenatal visits] effect, we stratified the final 
model by number of prenatal visits. To examine the mediator effect [pregnancy 
associated hypertension] we explored the effect of pre-pregnancy BMI on maternal 
morbidity first with and then without the mediator.  
The point estimates of an association between the independent factors and the 
outcome were expressed as odd ratios (OR) and described along with their 95% 
confidence intervals (CI). All reported P-Values were two -tailed and those <0.05 were 




 The study population included 74,059 participants. The Participants’ base line 
characteristics are shown in Table1A and 1B. Table 1A shows that 45.1% of the women 
had normal BMI while 26% were overweight and 25.3% were obese. Obese women 
tended to be Non-Hispanic white (49%), 20-24 years old (79.5%), had 8-15 prenatal 
visits (75.5%), and 9.8% diagnosed with Pregnancy associated hypertension. Of the 
74,059 participants, 355 had maternal morbidity (Table 2). Maternal morbidity was the 
highest among obese women (0.57%), followed by normal weight (0.49%), then 
overweight (0.42%), and finally underweight (0.22%). 
Table3: Unadjusted and adjusted Odds Ratios for Maternal Morbidity By Independent Variables, 74,059 





 Model 1 
Overall, the unadjusted model showed significant risk of maternal morbidity based on 
maternal pre-pregnancy body mass index; this model found that women with BMI ≥30 
[obese] were more likely to experience maternal morbidity when compared to other BMI 
classes. In the unadjusted model, the odds of maternal morbidity for obese women was 
2.5 times the odds of maternal morbidity in underweight women, In other words 
underweight women were 60% less likely to experience maternal morbidity compared to 
obese women while overweight women were 26% less likely compared to obese 
women, and women within the normal BMI class were 14% less likely to experience 
maternal morbidity compared to obese women (Table 3). 
The maternal age and maternal morbidity, women 35 years and above was at the 
highest risk for maternal morbidity. 
The association between race/ethnicity and maternal morbidity was not a surprise, 
given the well-established racial disparity in maternal morbidity, Non –Hispanic black 
women had the highest maternal morbidity when compared to other races. 
The number of prenatal care visits showed a J-shaped curve effect on maternal 
morbidity, where women with 8-15 prenatal visits were at the lowest risk for maternal 
morbidity.  
Pregnancy-Associated Hypertension is significantly associated with maternal morbidity, 
where women with pregnancy –associated hypertension showed greater risk for 
maternal morbidity than those without pregnancy–associated hypertension. 
     Model 2 
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After adjusting for maternal age and race, we found that there was still a significant 
association between BMI and maternal morbidity. The odds of maternal morbidity 
among obese women remained 2.5 times the odds of maternal morbidity among women 
with underweight BMI class. Underweight women [OR: 0.4 (0.2-1.0)] were 60% less 
likely to experience maternal morbidity compared to their obese counterparts.   
Women who are 35 years old and above were [OR: 1.9 (1.5-2.4)] 90% more likely to 
experience maternal morbidity than women who are 20-24 years old. 
Non-Hispanic whites were [OR: 0.6 (0.5-0.8)] 40% less likely to experience maternal 
morbidity than Non-Hispanic Black while Hispanics were [OR: 0.7 (0.5- 1.0)] 30% less 
likely compared to Non-Hispanic Black.   
    Model 3 
Model 3 was adjusting for maternal age, race, and pregnancy associated hypertension. 
We found that women who are 35 years old and above were [OR: 1.8 (1.4-2.3)] 80% 
more likely to experience maternal morbidity than women who are 20-24 years old. 
Non-Hispanic whites were [OR: 0.6 (0.5-0.8)] 40% less likely to experience maternal 
morbidity than Non-Hispanic Black. Underweight women [OR: 0.5 (0.2-1.1)] were 50% 
and overweight women [OR: 0.8 (0.6-1.1)] were 20% less likely to experience maternal 
morbidity compared to obese women. The odds of maternal morbidity are the same in 
both normal weight women [OR: 1.0 (0.8-1.3)] and obese women. Women with 
pregnancy associated hypertension are two times the women without pregnancy 
associated hypertension to experience maternal morbidity. Women with prenatal care 
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visits less than 8 [OR: 1.6 (1.3-2.2)] are 60% more likely to experience maternal 
morbidity than women with 8-15 visits. 
Mediator Effect: 
Consistent with partial mediation, adjusting for pregnancy associated hypertension 
decreased the odds of maternal morbidity by 10% among all the classes of pre-
pregnancy body mass index (Table4). 
Table 4:Mediator Effect 
 
Moderator Effect: 
Having 8-15 prenatal visits is a protective factor against maternal morbidity among 
women of all different body mass index classes, women 35 years old and above, and 
women with pregnancy associated hypertension (Table5). 





4- Discussion:  
This study is one of the first to examine the association between pre-pregnancy BMI 
and maternal morbidity for all births in the United States using birth certificates. It is less 
subject to bias such as sampling and non-response. Its findings are generalizable to the 
whole United States. The study has limitations. First, despite the large study size, there 
was insufficient statistical power to examine the association between pre-pregnancy 
BMI and maternal morbidity that required the formation of composite morbidity. Second, 
Medical and health information were underreported on the birth certificates.  
Although maternal morbidity is a rare condition, it is a crucial maternal health problem. 
The majority of the studies are based on data driven at the institutional or state level. It 
is difficult to examine maternal morbidity at a national level.  Studies that evaluate the 
validity of the birth certificate data are needed. This study recommends working on 
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creating a single and precise definition of maternal morbidity then incorporate the 
required date into the birth certificates.   
5- Conclusion: 
For many reasons Maternal morbidity is still challenging.  Maternal morbidity has a 
broad spectrum of presentation and severity and its definition could vary by different 
authors. It was hard to find literature focusing mainly on maternal morbidity without 
discussing maternal mortality. 
Most of the studies about maternal morbidity were based on data from the local 
institutes and hospitals which could consider a barrier against generalizing their results 
nationwide. On our literature review, we did not find studies based on data representing 
the general population of the United States. Our study is one of the first to examine this 
association for all births in the United States.  We recommend working on finding a clear 
definition for maternal morbidity and reporting maternal morbidity from all over the 
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